Praxis Precision Medicines, Inc.
PRAX · XNASCIK 1689548fmd_061WJWP3HZ04WKE3RZTSGDASF7Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2019 to Sep 30, 2026, 29 periods
Latest annual · FY2025
Millions- Total revenues
- 0
- Operating income
- (326)
- Net income
- (303)
- Free cash flow
- (249)
Latest quarter · Q3 FY2026
Millions- Operating income
- (107)
- Net income
- (94)
- Free cash flow
- (83)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2022 to FY2025
- n/m
- Revenue, 5 yearsFY2020 to FY2025
- n/m
- Net income, 5 yearsFY2020 to FY2025
- n/m
Praxis Precision Medicines, Inc. (PRAX) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2025 | FY2024 | Change | Source |
|---|---|---|---|---|
| Revenue | $0 | $8.6 million | -100% | 10-K 2026-02-19 · proof |
| Operating income | -$326.2 million | -$200.2 million | 10-K 2026-02-19 · proof | |
| Net income | -$303.3 million | -$182.8 million | 10-K 2026-02-19 · proof | |
| Cash from operating activities | -$249.1 million | -$131.8 million | 10-K 2026-02-19 · proof | |
| Free cash flow | -$249.1 million | -$131.8 million | 10-K 2026-02-19 · proof | |
| Total assets | $937.9 million | $483.1 million | +94.1% | 10-K 2026-02-19 · proof |
| Total liabilities | $59.8 million | $37.7 million | +58.7% | 10-K 2026-02-19 · proof |
| Cash and cash equivalents | $357.3 million | $215.4 million | +65.9% | 10-K 2026-02-19 · proof |
- What was Praxis Precision Medicines, Inc. (PRAX)'s revenue in fiscal 2025?
- Praxis Precision Medicines, Inc. (PRAX) reported revenue of $0 for fiscal 2025 (the year ended Dec 31, 2025), against $8.6 million the year before (-100%). Source: the 10-K filed with the SEC on Feb 19, 2026. SEC
- What was Praxis Precision Medicines, Inc. (PRAX)'s operating income in fiscal 2025?
- Praxis Precision Medicines, Inc. (PRAX) reported operating income of -$326.2 million for fiscal 2025 (the year ended Dec 31, 2025), against -$200.2 million the year before. Source: the 10-K filed with the SEC on Feb 19, 2026. SEC
- What was Praxis Precision Medicines, Inc. (PRAX)'s net income in fiscal 2025?
- Praxis Precision Medicines, Inc. (PRAX) reported net income of -$303.3 million for fiscal 2025 (the year ended Dec 31, 2025), against -$182.8 million the year before. Source: the 10-K filed with the SEC on Feb 19, 2026. SEC
- What was Praxis Precision Medicines, Inc. (PRAX)'s cash from operating activities in fiscal 2025?
- Praxis Precision Medicines, Inc. (PRAX) reported cash from operating activities of -$249.1 million for fiscal 2025 (the year ended Dec 31, 2025), against -$131.8 million the year before. Source: the 10-K filed with the SEC on Feb 19, 2026. SEC
- What was Praxis Precision Medicines, Inc. (PRAX)'s free cash flow in fiscal 2025?
- Praxis Precision Medicines, Inc. (PRAX) reported free cash flow of -$249.1 million for fiscal 2025 (the year ended Dec 31, 2025), against -$131.8 million the year before. Source: the 10-K filed with the SEC on Feb 19, 2026. SEC
- What are Praxis Precision Medicines, Inc. (PRAX)'s total assets?
- As of Dec 31, 2025, Praxis Precision Medicines, Inc. (PRAX) reported total assets of $937.9 million, against $483.1 million a year earlier (+94.1%). Source: the 10-K filed with the SEC on Feb 19, 2026. SEC
- What are Praxis Precision Medicines, Inc. (PRAX)'s total liabilities?
- As of Dec 31, 2025, Praxis Precision Medicines, Inc. (PRAX) reported total liabilities of $59.8 million, against $37.7 million a year earlier (+58.7%). Source: the 10-K filed with the SEC on Feb 19, 2026. SEC
- What are Praxis Precision Medicines, Inc. (PRAX)'s cash and cash equivalents?
- As of Dec 31, 2025, Praxis Precision Medicines, Inc. (PRAX) reported cash and cash equivalents of $357.3 million, against $215.4 million a year earlier (+65.9%). Source: the 10-K filed with the SEC on Feb 19, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:PRAX&period_type=annual&limit=5"Information only, not investment advice.